Int J Angiol 2016; 25(05): e89-e92
DOI: 10.1055/s-0034-1396947
Case Report
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Splenorenal Arterial Bypass: Description of Technique and Case Example in an Instance of Renal Revascularization during Adrenalectomy for Adrenocortical Carcinoma

J. Yozawitz
1   Department of Surgery, Hofstra North Shore–Long Island Jewish School of Medicine, Manhasset, New York
,
M. Kissin
2   Department of Vascular Surgery, Hofstra North Shore–Long Island Jewish School of Medicine, Manhasset, New York
,
M. Szuchmacher
2   Department of Vascular Surgery, Hofstra North Shore–Long Island Jewish School of Medicine, Manhasset, New York
,
J. Sullivan
3   Department of Surgical Oncology, Hofstra North Shore–Long Island Jewish School of Medicine, Manhasset, New York
,
J. Nicastro
1   Department of Surgery, Hofstra North Shore–Long Island Jewish School of Medicine, Manhasset, New York
,
G. Coppa
1   Department of Surgery, Hofstra North Shore–Long Island Jewish School of Medicine, Manhasset, New York
,
E. Molmenti
4   Department of Transplant Surgery, Hofstra North Shore–Long Island Jewish School of Medicine, Manhasset, New York
› Author Affiliations
Further Information

Publication History

Publication Date:
28 January 2015 (online)

Abstract

We present a patient with a 16 cm adrenocortical carcinoma that underwent a left adrenalectomy en bloc with resection of the involved segment of the left renal artery. A splenectomy and splenorenal bypass was performed to revascularize the left kidney. To our knowledge, this is the first instance in the literature of a splenorenal arterial bypass being reported for renal revascularization during an extirpative oncologic procedure. A 64-year-old male patient, with history significant for adrenocortical carcinoma, status post prior right adrenalectomy with partial right nephrectomy, presented for an elective left adrenalectomy. Preoperative work-up revealed an 11.4 × 13.2 × 16 cm left adrenal mass, most consistent with an adrenocortical carcinoma. At the time of surgery, the mass was found to be intimately adherent to the aorta at the takeoff of the left renal artery. Moreover, the left renal artery appeared to be coursing directly through the mass. The involved segment of the left renal artery was resected en bloc with the tumor. Because of concerns for a small and likely poorly functioning right renal remnant, a decision was made to attempt to salvage the left kidney. This was accomplished by performing a splenectomy and constructing a splenorenal bypass. Serial Duplex Doppler renal ultrasound studies were obtained over the first three postoperative days and demonstrated improved arterial waveforms. Serum creatinine reached a peak level of 3.76 mg/dL on postoperative day 3, and then began to slowly trend down to 3.37 mg/dL on the day of discharge (postoperative day7).

 
  • References

  • 1 Moncure AC, Brewster DC, Darling RC, Atnip RG, Newton WD, Abbott WM. Use of the splenic and hepatic arteries for renal revascularization. J Vasc Surg 1986; 3 (2) 196-203
  • 2 Khauli RB, Novick AC, Ziegelbaum M. Splenorenal bypass in the treatment of renal artery stenosis: experience with sixty-nine cases. J Vasc Surg 1985; 2 (4) 547-551
  • 3 Rigdon EE, Durham JR, Massop DW, Wright JG, Smead WL. Hepatorenal and splenorenal artery bypass for salvage of renal function. Ann Vasc Surg 1991; 5 (2) 133-137
  • 4 Brown MF, Graham JM, Mattox KL, Feliciano DV, DeBakey ME. Renovascular trauma. Am J Surg 1980; 140 (6) 802-805
  • 5 Gervaz P, McCollum PT, Naidu S. Splenorenal Bypass as an Emergency Procedure A Case Report. Vasc Endovascular Surg 1998; 32 (3) 287-290
  • 6 Valentine RJ, Rossi MB, Myers SI, Clagett GP. Splenic infarction after splenorenal arterial bypass. J Vasc Surg 1993; 17 (3) 602-606
  • 7 Zeiger MA, Thompson GB, Duh QY , et al; American Association of Clinical Endocrinologists; American Association of Endocrine Surgeons. American association of clinical endocrinologists and American association of endocrine surgeons medical guidelines for the management of adrenal incidentalomas. Endocr Pract 2009; 15 (Suppl. 01) 1-20